Literature DB >> 6256029

Ectoenzymes on the surface of cells from human lymphoblastoid lines: 5'-nucleotidase and phosphatase.

W Gutensohn, L G Gürtler, W Siegert, E Eichler, S Ernst.   

Abstract

Activities of the ecto-enzymes 5'-nucleotidase (5'-N) and phosphatase were determined on the surface of intact cells from 15 different established lines of human B- and T-lymphoblasts. Whereas all the lines express phosphatase, 10 of the lines were negative for 5'-N. 5'-N-negative cell lines are found among B as well as T cells, and they do not carry cryptic enzyme activity. In a 5'-N-positive line activity of this enzyme is correlated with growth showing a peak during the logarithmic phase. On the other hand, inhibition of 5'-N does not change the growth curve of this line. Neuraminidase treatment of the cell surface brings about an increase in phosphatase but not in 5'-N activity. 5'-N of two B-cell lines of human peripheral blood lymphocytes shows complete crossreactivity with an antiserum obtained against human placental 5'-N. However, the enzyme of one lymphoma line with B-cell properties (EHR-A-Ramos) does not cross-react with this serum. The results are discussed with respect to suitability of these lymphoblast lines as model systems for the study of immunodeficiencies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6256029     DOI: 10.1007/bf01007765

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  20 in total

1.  Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.

Authors:  K O Fresen; H Hausen
Journal:  Int J Cancer       Date:  1976-02-15       Impact factor: 7.396

2.  An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.

Authors:  G Klein; B Giovanella; A Westman; J S Stehlin; D Mumford
Journal:  Intervirology       Date:  1975       Impact factor: 1.763

3.  Purine metabolism in lymphocytes from patients with primary hypogammaglobulinaemia.

Authors:  A D Webster; M North; J Allsop; G L Asherson; R W Watts
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

4.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

5.  Ecto-enzymes of the guinea pig polymorphonuclear leukocyte. I. Evidence for an ecto-adenosine monophosphatase, adenosine triphosphatase, and -p-nitrophenyl phosphates.

Authors:  J W DePierre; M L Karnovsky
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

6.  Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji).

Authors:  M A Epstein; B G Achong; Y M Barr; B Zajac; G Henle; W Henle
Journal:  J Natl Cancer Inst       Date:  1966-10       Impact factor: 13.506

7.  A simple microradioisotopic assay for 5'-nucleotidase activity. Application to central nervous tissues.

Authors:  A A Suran
Journal:  Anal Biochem       Date:  1973-10       Impact factor: 3.365

8.  Lymphocyte purine 5'-nucleotidase edficiency in primary hypogammaglobulinaemia.

Authors:  S M Johnson; M E North; G L Asherson; J Allsop; R W Watts; A D Webster
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

9.  Human lymphocytes: 5'-nucleotidase-positive and -negative subpopulations.

Authors:  R Silber; M Conklyn; G Grusky; D Zucker-Franklin
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

10.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.

Authors:  G Klein; T Lindahl; M Jondal; W Leibold; J Menézes; K Nilsson; C Sundström
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

View more
  3 in total

1.  Evaluation of 5'-nucleotidase as biochemical marker in leukemias and lymphomas.

Authors:  W Gutensohn; E Thiel; B Emmerich
Journal:  Klin Wochenschr       Date:  1983-01-03

2.  Independent expression of the surface markers 5'-nucleotidase and cALLA on leukemic cells.

Authors:  W Gutensohn; B Wünsch; H Rodt
Journal:  Blut       Date:  1983-04

3.  5'-Nucleotidase activity in subjects with abnormal lymphocyte function.

Authors:  P S Gerber; H G Herrod
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.